Skip to main content
SpringerLink
Log in

Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

In order to provide evidence for evidence-based medicine in the treatment and prognosis of laryngeal cancer in China, the meta-analysis electronically retrieved the case-control studies published in China about the Survivin expression and its association with clinical pathological features in the tissues of laryngeal carcinoma. The results showed that a total of 25 case-control studies were finally included with 1333 cases of laryngeal cancer and 528 cases of controls. The difference in the expression of Survivin between the two groups was statistically significant [OR=18.34, 95% CI (11.82, 28.47), P<0.00001]. The difference in the expression of Survivin between laryngeal carcinoma patients with lymph node metastasis or not was statistically significant [OR=0.25, 95% CI (0.17, 0.37), P<0.00001]. The expression of Survivin in clinical I–II stage group was significantly lower than in the clinical stage III–IV group [OR=0.24, 95% CI (0.18, 0.32), P<0.00001]. The expression of Survivin in patients with low/medium differentiation was significantly lower than that in those with high differentiation [OR=0.33, 95% CI (0.26, 0.43), P<0.00001]. The difference in the expression of Survivin among different T stages of laryngeal carcinoma was statistically significant [OR=0.35, 95% CI (0.21, 0.58), P<0.00001]. In conclusion, Survivin may play an important role in the occurrence and development of laryngeal carcinoma, and its high expression is related to the poor prognosis of patients with laryngeal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen X, Duan N, Zhang C, et al. Survivin and tumorigenesis: Molecular mechanisms and therapeutic strategies. J Cancer, 2016,7(3):314–323

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Wang Y, Jiang LL, Wu JF, et al. Protective effect of Honokiol against endometriosis in rats via attenuating Survivin and Bcl-2: A mechanistic study. Cell Mol Biol (Noisy-le-grand), 2016,62(1):1–5

    Google Scholar 

  3. Yuan W, Zhang C, Feng H, et al. Einstein probe—a small mission to monitor and explore the dynamic X-ray universe. J Huazhong Univ Sci Technol Med Sci, 2015,23(4):383–386

    Google Scholar 

  4. Marioni G, Agostini M, Bedin C, et al. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants. Histopathology, 2012,61(2):247–256

    Article  PubMed  Google Scholar 

  5. Yang X, Li X, An L, et al. Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and downregulating survivin expression. Eur Arch Otorhinolaryngol, 2013,270(8):2289–2297

    Article  PubMed  Google Scholar 

  6. Bai YF, Tan J, Peng SD. Expression of Survivin and VEGF in laryngeal carcinoma and clinical significance. Zhongguo Erbiyanhouludi Waike Zazhi (Chinese). 2012,18(1):5–9

    Google Scholar 

  7. Chen YF, Chen FJ, Fang Y, et al. Survivin expression in laryngeal squamous cell carcinoma and its relationship with clinical factors. Chin J Cancer, 2004,23(23):1493–1497

    Google Scholar 

  8. Di B, Li XM, Lu XY, et al. Expression of survivin in laryngeal cancer. Zhongguo Erbiyanhouludi Waike Zazhi (Chinese), 2005,12(2):81–84

    Google Scholar 

  9. Fu LP, Lu YS, Guo J, et al. Clinical significance of the expression of survivin in squamous cell of carcinoma of larynx. Zhongguo Redai Yixue (Chinese), 2005,5(4):661–662

    Google Scholar 

  10. Guan Z, Ye H, Peng JR, et al. Relationship between expression of Survivin and prognosis in human laryngeal squamous cell carcinoma. J Cancer, 2004,23(6):693–696

    CAS  Google Scholar 

  11. Guo BF, Dong MM, Zhang YH, et al. Expression of P53, Bcl2, and Bax in laryngeal squamous cell carcinoma tissue. Zhengzhou Daxue Xuebao (Yixueban) (Chinese), 2005,40(1):70–73

    CAS  Google Scholar 

  12. He L. Clinical significance of expression of PTEN and survivin in laryngeal squamous cell carcinoma and lymph node metastases. Jinan University (Chinese), 2005

    Google Scholar 

  13. Jiang LL, Han RZ, Xu XY, et al. Expression of survivin, bcl-2 and bax in laryngeal squamous cell carcinoma. Zhongliu (Chinese), 2006,26(2):163–167

    Google Scholar 

  14. Li C, Ma Z, Xiao G, et al. Expression of apoptosis inhibitor Survivin in laryngeal carcinoma cells and clinical significance of expressed product. Zhongguo Shengwu Zhipin Zazhi (Chinese), 2004,17(2):110–112

    Google Scholar 

  15. Li DW, Dong P, Sun ZF, et al. Expression of survivin and its correlation with proliferation and apoptosis in laryngeal squamous cell carcinoma. Linchuang Zhongliuxue Zazhi (Chinese), 2010,15(11):966–969

    Google Scholar 

  16. Li F, Zhao SY. The expressions of Survivin and EIF4e in laryngeal squamous cell carcinoma and their correlation. Qilu Yixue Zazhi (Chinese), 2009,24(2):101–103

    CAS  Google Scholar 

  17. Li H, Li MH, Deng AC, et al. The expression of Survivin in laryngeal cancer and its significance. Zhongguo Zhongliu (Chinese), 2008,17(5):411–412

    Google Scholar 

  18. Liang ZP, Yu L, Chen ZR, et al. Expression and clinical significance of COX-2 and Survivin in laryngeal carcinoma. Zhongguo Erbiyanhouludi Waike Zazhi (Chinese), 2009,15(1):6–11

    CAS  Google Scholar 

  19. Lin LQ, Zhang YL, Yin XM, et al. Expression and significance of survivin and livin in laryngeal squamous cell carcinoma tissue. Shandong Yiyao (Chinese), 2010,50(19):40–41

    CAS  Google Scholar 

  20. Liu XJ, Liu GJ, Fan QJ, et al. Expression of apoptosis suppressor gene survivin and p63 in laryngeal carcinoma and its significance. Shanghai Yixue (Chinese), 2010,33(11):1048–1049

    Google Scholar 

  21. Ren Y, Shen Z, Ding H, et al. Expressions of HuR and survivin in laryngeal cancer and its clinical significance. Xiandai Shiyong Yixue (Chinese), 2011,23(8):855–858

    Google Scholar 

  22. Sun J, Xin L, Yuan Y, et al. Expression and significance of apoptosis inhibitor survivin in laryngeal carcinoma. Shandong Daxue Erbihouyan Xuebao (Chinese), 2006,20(5):441–443

    Google Scholar 

  23. Sun M, Qin Y. Expression of survivin and its correlation with p53 and bcl-2 expression in laryngeal and hypopharyngeal cancer. Linchuang Zhongliuxue Zazhi (Chinese), 2008,22(8):346–348

    Google Scholar 

  24. Wang J, Guan C, Wang S, et al. Expression of Survivin and Bcl-2 in laryngeal squamous cell carcinoma and their significance. Linchuang Zhongliuxue Zazhi (Chinese), 2005,19(6):247–249

    Google Scholar 

  25. Wen LJ, Li CQ, Sun YX, et al. Expression and implication of survivin gene in laryngeal carcinoma. Zhongguo Erbiyanhoutoujing Waike (Chinese), 2004,11(5):327–329

    Google Scholar 

  26. Wen X, Ji WY. Expression and biological significance of survivin and Bcl-2 in laryngeal squamous cell carcinoma. Zhongguo Xiandai Yixue Zazhi (Chinese), 2006,16(9):1335–1337

    CAS  Google Scholar 

  27. Xu JX, Li SS, Dong XL, et al. Expression of Survivin gene in laryngeal squamous cell carcinoma and its correlation with Bcl-2 and p53 gene expression. Linchuang Zhongliuxue Zazhi (Chinese), 2004,18(8):490–491

    Google Scholar 

  28. Zhang HB, Zhang DG, Pan XL, et al. STAT3 expression in laryngeal carcinoma tissues and its relation with Survivin expression. Shandong Daxue Erbihouyan Xuebao (Chinese), 2008,22(2):123–126

    Google Scholar 

  29. Zhu J, Xu RJ, Wu ZH, et al. Expression of Survivin gene and its relationship with expression of p15, p16 proteins in laryngeals squamous cell carcinomas. Zhonghua Erbiyanhouke Zazhi (Chinese), 2004,39(39):356–359

    Google Scholar 

  30. Zhu S, Wang S. Expression and clinical significance of Survivin gene and PTEN gene in laryngeal squamous cell carcinomas. Linchuang Erbiyanhouke Zazhi (Chinese), 2006,20(24):1113–1115

    Google Scholar 

  31. Demir D, Yaman B, Anacak Y, et al. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma. Turk Patoloji Derg, 2014,30(1):55–65

    PubMed  CAS  Google Scholar 

  32. Fernandez JG, Rodriguez DA, Valenzuela M, et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced beta-catenin/Tcf-Lef dependent transcription. Mol Cancer, 2014,13(1):1–15

    Article  CAS  Google Scholar 

  33. Habib R, Akhtar J, Taqi M, et al. Lentiviral vectormediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth. Oncol Rep, 2015,34(2):859–867

    Article  PubMed  CAS  Google Scholar 

  34. Liu TS, Cai YT, Mao ZF, et al. Dynamic imaging of autophagy-lysosomal pathway and autophagy function following pulmonary hypoxia/reoxygenation in vitro. J Huazhong Univ Sci Technol Med Sci, 2015,35(2):302–308

    Article  PubMed  CAS  Google Scholar 

  35. Rivadeneira DB, Caino MC, Seo JH, et al. Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Sci Signal, 2015,8(389):ra80

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Zhang K, Li Y, Liu W, et al. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vitro. Mol Med Rep, 2015,11(1):639–644

    Article  PubMed  CAS  Google Scholar 

  37. Dziegielewska B, Casarez EV, Yang WZ, et al. Abstract 5407: T-type Ca2+ channel inhibitors sensitize ovarian cancer to carboplatin through downregulation of survivin gene expression. Cancer Res, 2015,75(15 Supplement):5407–5407

    Article  Google Scholar 

  38. Jafarlou M, Baradaran B, Shanehbandi D, et al. siRNAmediated inhibition of survivin gene enhances the anticancer effect of etoposide in U-937 acute myeloid leukemia cells. Cell Mol Biol (Noisy-le-grand), 2016,62(6):44–49

    CAS  Google Scholar 

Download references

Author information

Author notes

  1. The two authors contributed equally to this work.

Authors and Affiliations

  1. Department of Medical Records and Statistics, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China

    Juan Geng  (耿 娟) & Sheng-guang Pei  (裴圣广)

  2. Department of Oncology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China

    Yan-rong Lei  (雷艳荣)

Authors
  1. Juan Geng  (耿 娟)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan-rong Lei  (雷艳荣)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sheng-guang Pei  (裴圣广)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sheng-guang Pei  (裴圣广).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Geng, J., Lei, Yr. & Pei, Sg. Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis. CURR MED SCI 37, 965–973 (2017). https://doi.org/10.1007/s11596-017-1835-4

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-017-1835-4

Key words

Search

Navigation